ATAC-Seq: The Definitive Guide to Chromatin Accessibility, Protocols, and Low-Bias Kits
Go beyond Tn5. Learn the core principles of the Assay for Transposase-Accessible Chromatin (ATAC-Seq) and discover how the EpiNext™ Kit provides faster, low-bias results for nucleosome positioning and regulatory mapping.
ATAC-Seq (Assay for Transposase-Accessible Chromatin using sequencing) is a leading method for profiling genome-wide chromatin accessibility. This technique identifies regions of open, loosely packed DNA that are accessible to regulatory proteins like transcription factors (TFs). Mapping these accessible sites is crucial for understanding epigenetic gene regulation and cellular differentiation.
Since its introduction, ATAC-Seq has become a leading standard in chromatin accessibility analysis, and in many applications has replaced older, cell-intensive methods like DNase-seq and MNase-seq. However, the original protocol, which relies on the hyperactive Tn5 transposase, introduces several well-documented technical limitations, including:
Fragmentation Bias: The Tn5 enzyme has intrinsic insertion preferences, leading to skewed accessibility results.
Standardization Difficulty: Critical cell counting and enzyme titration steps are often difficult to standardize across different sample types.
The Core Biological Goal: Mapping Active Regulatory Elements
By mapping accessible chromatin, researchers can pinpoint active promoters, enhancers, and regions where TFs are actively binding. The resulting fragment patterns also allow for high-resolution analysis of nucleosome positioning—a direct readout of chromatin structure dynamics.
The EpiNext™ Fast Kit: Low-Bias Mechanism and Speed Advantage
The EpiNext™ Chromatin Accessibility Sequencing Fast Kit (P-1071) was specifically engineered to address the technical shortcomings of Tn5-based protocols while preserving the speed and sensitivity required for modern genomics.
Unique Principle: Cleavage & Ligation vs. Tagmentation
Instead of relying on Tn5 tagmentation, the EpiNext™ kit utilizes a proprietary unique nucleic acid cleavage enzyme mix. The process fundamentally differs:
Targeted Cleavage: The unique enzyme complex selectively cleaves and removes DNA sequences flanking the target chromatin while leaving protein/histone-occupied DNA intact, ensuring high specificity for relevant chromatin regions.
Reduced Bias: Because this unique mix enables largely sequence-independent cleavage compared with Tn5, the resulting library shows reduced fragmentation and GC/AT content bias, yielding more accurate accessibility profiles.
Direct Ligation: Sequencing adaptors are then directly ligated onto the cleaved ends of the protected fragments. The resulting library is highly representative of the underlying chromatin accessibility landscape.
Unmatched Protocol Speed
The optimized three-step protocol dramatically reduces hands-on and total time required:
Total Time: 1 hour and 55 minutes (sample to sequencing-ready DNA).
Input Versatility: Proven efficacy with challenging inputs like fresh/frozen tissues (starting at 5 mg), as well as cells (starting at 50,000 cells).
EpiNext™ vs. ATAC-Seq: A Head-to-Head Comparison
For researchers seeking minimal bias and maximum efficiency in chromatin accessibility studies, the EpiNext™ kit offers measurable performance gains over the standard Tn5 protocol.
Feature
Standard ATAC-Seq (Tn5)
EpiNext™ Fast Kit (P-1071)
Core Mechanism
Tn5 Tagmentation (Cut & Paste)
Unique Cleavage & Adapter Ligation
Protocol Time
~4 hours
1 hour 55 minutes
Fragmentation Bias
High (due to Tn5 sequence specificity)
Significantly reduced
Mitochondrial Contamination
High (often requires Omni-ATAC variation)
Minimized (protocol-optimized to reduce mitochondrial reads)
Input Material
Cells (more challenging with tissue/frozen samples)
The kit is designed for simplicity, reproducibility, and high library yield.
Step 1: Cell/Tissue Lysis and Nuclei Isolation
The provided Lysis Buffer is optimized to effectively permeabilize cell membranes while preserving nuclear structure and limiting mitochondrial disruption. This step is key to the kit's success in mitigating background fragments, particularly in tissue samples which require gentle disaggregation.
Step 2: Chromatin Fragmentation and Adapter Ligation
This is the central reaction performed by the unique cleavage enzyme mix. The short incubation time ensures controlled fragmentation and highly specific labeling of the target chromatin regions. The ligated DNA is then immediately purified using the provided reagents.
Step 3: Library Purification and PCR Amplification
Following purification, the ligated fragments are amplified using a high-fidelity PCR mix with barcoded primers for multiplexed Illumina sequencing. The optimal input range is crucial: use 50,000 to 500,000 cells or 5 to 50 mg of tissue to ensure adequate library complexity while avoiding over-amplification bias.
Data Analysis: Quality Metrics and Footprinting
High-quality sequencing data generated by the EpiNext™ kit yields robust biological insights due to its lower background noise and reduced bias.
TSS Enrichment: This critical QC metric should show a strong, sharp peak at transcription start sites (TSS), indicating successful targeting of active promoters.
Fragment Distribution: Libraries should show the characteristic periodic pattern of small nucleosome-free fragments (NFRs, <100 bp) and subsequent mono- and di-nucleosome fragments (~200 bp and ~400 bp).
Transcription Factor Footprinting: The method's ability to precisely map protected, protein-bound DNA makes it an excellent platform for TFBS footprinting—identifying base pairs protected by a bound TF.
Differential Accessibility: After mapping and peak calling, differential analysis (using tools such as DiffBind) identifies regulatory elements that change in accessibility between different cell states or conditions.
EpiNext™ Chromatin Accessibility Sequencing Fast Kit (P-1071)
Choose the EpiNext™ kit for low-bias, high-speed chromatin accessibility mapping.